Susquehanna Fundamental Investments, LLC Intercept Pharmaceuticals, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$11.61 - $16.11 $508,796 - $706,004	-43,824 Reduced 47.72%	48,008 $593,000
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $921,635 - $1.49 Million	75,482 Added 461.66%	91,832 $1.28 Million
Q4 2021 Feb 14, 2022	SELL	$14.28 - $19.53 $681,570 - $932,147	-47,729 Reduced 74.48%	16,350 $266,000
Q3 2021 Nov 15, 2021	BUY	$12.99 - $20.47 $212,386 - $334,684	16,350 Added 34.26%	64,079 $952,000
Q2 2021 Aug 11, 2021	BUY	$15.46 - $24.5 $737,890 - $1.17 Million	47,729 New	47,729 $953,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.